KAVL - MFGP SRNE and OPEN among pre market losers
AC Immune (ACIU) -32% as crenezumab fails in Alzheimer's study. Cango (CANG) -30%. Absci (ABSI) -14%. Hillstream BioPharma (HILS) -11%. Cepton (CPTN) -7%. Enservco Corporation (ENSV) -10%. Arcellx (ACLX) -10% on upsizing of follow-on public offering of 7M shares at $16/share. Koninklijke Philips (PHG) -10% as UBS downgrades to Sell citing impact of product recall. Tremor International (TRMR) -8%. MSP Recovery (MSPR) -7%. Kaival Brands Innovations (KAVL) -7%. Agenus (AGEN) -6%. GreenBox (GBOX) -6%. Indonesia Energy (INDO) -7%. GeoVax Labs (GOVX) -6%. Opendoor Technologies (OPEN) -6%. Aterian (ATER) -6%. Sorrento Therapeutics (SRNE) -6%. AeroClean Technologies (AERC) -6%. Micro Focus International (MFGP) -6%. Golden Ocean (GOGL) -6%. Integrated Media Technology (IMTE) -6%. Uranium Energy (UEC) -6%. Teck Resources (TECK) -6%.
For further details see:
MFGP, SRNE and OPEN among pre market losers